Abstract
Silybin is a composition of the silymarin group as a hepatoprotective agent, and it exhibits various biological activities, including an antibacterial activity. In this study, the effects of a combination of silybin with N,N′-dicyclohexylcarbodiimide (DCCD) against clinical isolates of Pseudomonas aeruginosa were investigated. In the results of susceptibility assay, silybin showed more potent antibacterial activity in methicilin-resistant Staphylococcus aureus (MRSA) than in P. aeruginosa, but DCCD significantly increased the antibacterial activity of silybin in P. aeruginosa. The antibacterial activity of silybin was affected by the strong action of multidrug-resistant pumps rather than by a permeable disruption of lipopolysaccharide and silybin showed a remarkable synergistic activity in combination with some antibiotic agents against drug-resistant bacteria. Therefore, silybin has a potential as a combination therapeutic agent for treatment of infectious diseases by multidrug-resistant bacteria.
Similar content being viewed by others
References
Agarwal, C., R.P. Singh, S. Dhanalakshmi, A.K. Tyagi, M. Tecklenburg, R.A. Sclafani, and R. Agarwal. 2003. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22, 8271–8282.
Cha, J.D., M.R. Jeong, S.I. Jeong, and K.Y. Lee. 2007. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens. J. Microbiol. Biotechnol. 17, 858–864.
Chen, C.J., J.E. Chin, K. Ueda, D.P. Clark, I. Pastan, M.M. Gottesman, and I.B. Roninson. 1986. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47, 381–389.
Davidson, A.L. and J. Chen. 2004. ATP-binding cassette transporters in bacteria. Annu. Rev. Biochem. 73, 241–268.
De Kievit, T.R., M.D. Parkins, R.J. Gillis, R. Srikumar, H. Ceri, K. Poole, B.H. Iglewski, and D.G. Storey. 2001. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 45, 1761–1770.
Gibbons, S. and E.E. Udo. 2000. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant. Phytother. Res. 14, 139–140.
Goncalves, P.P., S.M. Meireles, P. Neves, and M.G. Vale. 1999. Synaptic vesicle Ca2+/H+ antiport: dependence on the proton electrochemical gradient. Mol. Brain Res. 71, 178–184.
Gradelski, E., L. Valera, D. Bonner, and J. Fung-Tomc. 2001. Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species. Antimicrob. Agents Chemother. 45, 3220–3222.
Gupta, O.P., S. Sing, S. Bani, N. Sharma, S. Malhotra, B.D. Gupta, S.K. Banerjee, and S.S. Handa. 2000. Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase. Phytomedicine 7, 21–24.
Hancock, R.E. and P.G. Wong. 1984. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob. Agents Chemother. 26, 48–52.
Hooper, D.C. 2005. Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. Clin. Infect. Dis. 40, 1811–1817.
Irvin, R.T., T.J. Macalister, and J.W. Costerton. 1981. Tris(hydroxymethyl) aminomethane buffer modification of Escherichia coli outer membrane permeability. J. Bacteriol. 145, 1397–1403.
Jernaes, M.W. and H.B. Steen. 1994. Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. Cytometry 17, 302–309.
Jung, H.J., Y.B. Seu, and D.G. Lee. 2007. Candicidal action of resveratrol isolated from grapes on human pathogenic yeast C. albicans. J. Microbiol. Biotechnol. 17, 1324–1329.
Kren, V. and D. Walterova. 2005. Silybin and silymarin-new effects and applications. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub. 149, 29–41.
Leavis, H.L., R.J. Willems, J. Top, E. Spalburg, E.M. Mascini, A.C. Fluit, A. Hoepelman, A.J. De Neeling, and M.J. Bonten. 2003. Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg. Infect. Dis. 9, 1108–1115.
Lee, E.W., M.N. Huda, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003a. EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis. Antimicrob. Agents Chemother. 47, 3733–3738.
Lee, D.G., H.K. Kim, Y. Park, S.C. Park, E.R. Woo, H.G. Jeong, and K.S. Hahm. 2003b. Gram-positive bacteria specific properties of silybin derived from Silybum marianum. Arch. Pharm. Res. 26, 597–600.
Leive, L. 1965. Actinomycin sensitivity in Escherichia coli produced by Edta. Biochem. Biophys. Res. Commun. 18, 13–17.
Levy, S.B. 1992. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36, 695–703.
Lewis, K. 1994. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem. Sci. 19, 119–123.
Lewis, K. 2001. In search of natural substrates and inhibitors of MDR pumps. J. Mol. Microbiol. Biotechnol. 3, 247–254.
Lomovskaya, O. and K. Lewis. 1992. Emr, an Escherichia coli locus for multidrug resistance. Proc. Natl. Acad. Sci. USA 89, 8938–8942.
Linnett, P.E. and R.B. Beechey. 1979. Inhibitors of the ATP synthethase system. Methods Enzymol. 55, 472–518.
Mcmurry, L., R.E. Petrucci, Jr., and S.B. Levy. 1980. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. USA 77, 3974–3977.
Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593–656.
Perez-Victoria, J.M., F.J. Perez-Victoria, G. Conseil, M. Maitrejean, G. Comte, D. Barron, A. Di Pietro, S. Castanys, and F. Gamarro. 2001. High-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin. Antimicrob. Agents Chemother. 45, 439–446.
Renau, T.E., R. Leger, E.M. Flamme, J. Sangalang, M.W. She, R. Yen, C.L. Gannon, D. Griffith, S. Chamberland, O. Lomovskaya, S.J. Hecker, V.J. Lee, T. Ohta, and K. Nakayama. 1999. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42, 4928–4931.
Sharma, G., R.P. Singh, D.C. Chan, and R. Agarwal. 2003. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. Anticancer Res. 23, 2649–2655.
Singh, R.P. and R. Agarwal. 2004. Prostate cancer prevention by silibinin. Curr. Cancer Drug Targets 4, 1–11.
Steinfels, E., C. Orelle, J.R. Fantino, O. Dalmas, J.L. Rigaud, F. Denizot, A. Di Pietro, and J.M. Jault. 2004. Characterization of YvcC (BmrA), a multidrug ABC transporter constitutively expressed in Bacillus subtilis. Biochemistry 43, 7491–7502.
Stermitz, F.R., J. Tawara-Matsuda, P. Lorenz, P. Mueller, L. Zenewicz, and K. Lewis. 2000. 5′-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus. J. Nat. Prod. 63, 1146–1149.
Swallow, C.J., S. Grinstein, and O.D. Rotstein. 1990. A vacuolar type H(+)-ATPase regulates cytoplasmic pH in murine macrophages. J. Biol. Chem. 265, 7645–7654.
Tegos, G., F.R. Stermitz, O. Lomovskaya, and K. Lewis. 2002. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 46, 3133–3141.
Tyagi, A.K., C. Agarwal, D.C. Chan, and R. Agarwal. 2004. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol. Rep. 11, 493–499.
Van Den Berg Van Saparoea, H.B., J. Lubelski, R. Van Merkerk, P.S. Mazurkiewicz, and A.J. Driessen. 2005. Proton motive force-dependent Hoechst 33342 transport by the ABC transporter LmrA of Lactococcus lactis. Biochemistry 44, 16931–16938.
Van Der Heide, T. and B. Poolman. 2002. ABC transporters: one, two or four extracytoplasmic substrate-binding sites? EMBO Rep. 3, 938–943.
Wellington, K. and B. Jarvis. 2001. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 15, 465–489.
Yu, J.L., L. Grinius, and D.C. Hooper. 2002. NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes. J. Bacteriol. 184, 1370–1377.
Zgurskaya, H.I. and H. Nikaido. 1999. Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc. Natl. Acad. Sci. USA 96, 7190–7195.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jung, H.J., Lee, D.G. Synergistic antibacterial effect between silybin and N,N′-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates. J Microbiol. 46, 462–467 (2008). https://doi.org/10.1007/s12275-008-0138-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-008-0138-7